Tags: AMRAntimicrobial resistanceantimicrobial testingGlox Therapeutics\bacteriocin development programme\
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Stephen Clark Ars Technica Senior Space Editor. Houston, Texas | ||
| 2 | MedPage Today Staff MedPage Today Explains healthcare complexities. Not endorsements. New York, New York | ||
| 3 | Siôn Geschwindt Next Web The Heart of Tech ❤️ Amsterdam, The Netherlands | US firm Realwear acquires Swiss startup Almer amid XR market consolidation - about 1 month ago | |
| 4 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | FLASCO Fall Session: Advancements in MRD Monitoring Using ctDNA in Lung Cancer - about 2 months ago | |
| 5 | Chris Clow HousingWire Editor at @rmdaily Seattle, Washington | NRMLA elects new board members, officers for 2025 term - about 2 months ago | |
| 6 | Nish Amarnath Utility Dive Editor and author. Connected with @industrydive. New York, New York | ||
| 7 | Stewart Burnett Automotive World Voice of the remarketing & used car sectors. | ||
| 8 | Rachael Robertson MedPage Today Investigations & enterprise writer. Covers ob/gyn. @medpagetoday. NYC via PGH | Leaked AAMC Emails Reveal Concern About ERAS Exodus - 10 months ago AAMC Overhauls Pricing for Residency Applications - 11 months ago | |
| 9 | Marissa Plescia MedCity News Reporter at MedCity News. | AMA Report Details Low Competition in PBM Market - 3 months ago | |
| 10 | John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California | AMBLor prognostic melanoma biomarker receives UKCA Mark - 4 months ago |